Tuesday, August 25, 2020

 

21 hours ago - Compounding of medications, such as crushing tablets and dispersing the contents of capsules, is a common practice in pharmacies and hospitals worldwide ...

 

 

 

 

Resources for Animal Food Producers in Southeast and Gulf Coasts Affected by Storms Marco and Laura

 

Resources for Animal Food Producers in Southeast and Gulf Coasts Affected by Storms Marco and Laura
As storms Marco and Laura approach the Southeast and Gulf Coasts of the United States, the U.S. Food and Drug Administration’s Center for Veterinary Medicine reminds those who may be affected by storm waters about resources available for animal food producers who may be harvesting, mixing, storing or distributing grains and other foods for animals.

The FDA reminds harvesters that crops harvested from flooded fields are often unacceptable because of contamination. Flood waters, which are different from pooled rain water, may contain sewage, pathogenic organisms, pesticides, chemical wastes, or other toxic substances. Mold growth is another serious concern for flood impacted crops intended for use in animal food. Some molds produce mycotoxins, which are toxic to certain animals and people.

Health Standards to Advance Transparency, Integrity, Science, Technology Infrastructure, and Confidential Statistics Act of 2020 (Health STATISTICS Act) - H.R.8080.

The House of Representatives has introduced a new bill, the "Health Standards to Advance Transparency, Integrity, Science, Technology Infrastructure, and Confidential Statistics Act of 2020 (Health STATISTICS Act) - H.R.8080."  The bill would direct the United States Department of Health and Human Services to share health data it collects from reporting entities with collected the Centers for Disease Control and Prevention, other public health agencies, and the public.  The bill would also require that the individual's privacy be maintained.

U.N. cautions that virus plasma treatment still experimental

 

The World Health Organization on Monday cautioned that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy, voicing the concern as a U.S. boost for the treatment has many scientists afraid formal studies will be derailed.

READ MORE >

Hahn Walks Back Plasma Claim; More Reinfections Reported; Antiviral Plane Seats — A daily roundup of news on COVID-19 and the rest of medicine by Elizabeth Hlavinka, Staff Writer, MedPage Today August 25, 2020

https://www.medpagetoday.com/infectiousdisease/covid19/88249?xid=nl_covidupdate_2020-08-25&eun=g649657d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=DailyUpdate_082520&utm_term=NL_Daily_Breaking_News_Active 

 Trump pushes for preelection fast-tracked approval of AstraZeneca COVID-19 vaccine: report